Logo image of IRON

DISC MEDICINE INC (IRON) Stock Price, Quote, News and Overview

NASDAQ:IRON - Nasdaq - US2546041011 - Common Stock - Currency: USD

43.55  +0.97 (+2.29%)

After market: 43.55 0 (0%)

IRON Quote, Performance and Key Statistics

DISC MEDICINE INC

NASDAQ:IRON (5/7/2025, 4:34:48 PM)

After market: 43.55 0 (0%)

43.55

+0.97 (+2.29%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High68.73
52 Week Low30.65
Market Cap1.51B
Shares34.63M
Float27.03M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-19 2025-05-19/bmo
IPO08-12 2020-08-12


IRON short term performance overview.The bars show the price performance of IRON in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20

IRON long term performance overview.The bars show the price performance of IRON in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of IRON is 43.55 USD. In the past month the price increased by 27.04%. In the past year, price increased by 43.45%.

DISC MEDICINE INC / IRON Daily stock chart

IRON Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.31 332.73B
AMGN AMGEN INC 13.29 148.31B
GILD GILEAD SCIENCES INC 12.78 123.13B
VRTX VERTEX PHARMACEUTICALS INC N/A 111.78B
REGN REGENERON PHARMACEUTICALS 12.66 60.56B
ARGX ARGENX SE - ADR 327.86 38.04B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 35.97B
ONC BEIGENE LTD-ADR N/A 25.03B
BNTX BIONTECH SE-ADR N/A 22.31B
NTRA NATERA INC N/A 21.77B
SMMT SUMMIT THERAPEUTICS INC N/A 18.04B
BIIB BIOGEN INC 7.41 17.17B

About IRON

Company Profile

IRON logo image Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company is headquartered in Watertown, Massachusetts and currently employs 84 full-time employees. The company went IPO on 2020-08-12. The firm's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. The company is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Company Info

DISC MEDICINE INC

321 Arsenal Street, Suite 101

Watertown MASSACHUSETTS US

Employees: 78

IRON Company Website

IRON Investor Relations

Phone: 16176749274

DISC MEDICINE INC / IRON FAQ

What is the stock price of DISC MEDICINE INC today?

The current stock price of IRON is 43.55 USD. The price increased by 2.29% in the last trading session.


What is the ticker symbol for DISC MEDICINE INC stock?

The exchange symbol of DISC MEDICINE INC is IRON and it is listed on the Nasdaq exchange.


On which exchange is IRON stock listed?

IRON stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for DISC MEDICINE INC stock?

17 analysts have analysed IRON and the average price target is 100.37 USD. This implies a price increase of 130.47% is expected in the next year compared to the current price of 43.55. Check the DISC MEDICINE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DISC MEDICINE INC worth?

DISC MEDICINE INC (IRON) has a market capitalization of 1.51B USD. This makes IRON a Small Cap stock.


How many employees does DISC MEDICINE INC have?

DISC MEDICINE INC (IRON) currently has 78 employees.


What are the support and resistance levels for DISC MEDICINE INC (IRON) stock?

DISC MEDICINE INC (IRON) has a support level at 42.57 and a resistance level at 48.35. Check the full technical report for a detailed analysis of IRON support and resistance levels.


Should I buy DISC MEDICINE INC (IRON) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DISC MEDICINE INC (IRON) stock pay dividends?

IRON does not pay a dividend.


When does DISC MEDICINE INC (IRON) report earnings?

DISC MEDICINE INC (IRON) will report earnings on 2025-05-19, before the market open.


What is the Price/Earnings (PE) ratio of DISC MEDICINE INC (IRON)?

DISC MEDICINE INC (IRON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.99).


What is the Short Interest ratio of DISC MEDICINE INC (IRON) stock?

The outstanding short interest for DISC MEDICINE INC (IRON) is 10.14% of its float. Check the ownership tab for more information on the IRON short interest.


IRON Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to IRON. When comparing the yearly performance of all stocks, IRON is one of the better performing stocks in the market, outperforming 86.36% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IRON Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IRON. While IRON seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IRON Financial Highlights

Over the last trailing twelve months IRON reported a non-GAAP Earnings per Share(EPS) of -3.99. The EPS decreased by -16.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -22.01%
ROE -24.65%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%-8.89%
Sales Q2Q%N/A
EPS 1Y (TTM)-16.67%
Revenue 1Y (TTM)N/A

IRON Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to IRON. The Buy consensus is the average rating of analysts ratings from 17 analysts.


Ownership
Inst Owners67.45%
Ins Owners1.13%
Short Float %10.14%
Short Ratio6.16
Analysts
Analysts84.71
Price Target100.37 (130.47%)
EPS Next Y-25.52%
Revenue Next YearN/A